The Department of Materials Engineering at the University of Technology awarded a master’s degree to the student Iman Hussein Radhiwi, Department of Materials Engineering / University of Technology for her thesis. Titled
“An Ecofriendly MXene (Ti3AlC2) Modified ZnO Heterostructured Nanophotocatalyst For Rapid Removal Real Pharmaceuticals Wastewater Under Simulated Solar Light”
Where the discussion took place in the Graduate Studies Hall in Building B in the department on Thursday, 26/5/2021 at nine in the morning, and the discussion committee consisted of Messrs.
1. Asst.prof.Dr. Laith Waddah Ismail, chairman
2. Asst.prof.Dr Mahmoud Khazal Hammadi Member
3. Lect. Dr. Basma Hashem Mohammed Member
4. Prof. Dr . Ahmed Mohamed Hassan Al-Ghabban is a Supervising Member
5.Asst.prof.Dr. Khaled Khudair Abbas is a Supervising Member
As well as a scientific evaluation of the thesis by a professor. Dr. Ammar Emad Kazem/ University of Babylon/ College of Materials Engineering, and Prof. Dr. Qusai Fadel Abdel Hamid/ University of Technology/ Department of Chemical Engineering, and linguistically by Asst. Prof.Dr. Mayada Shanan Abd/ University of Technology/ Department of Materials Engineering
After the discussion committee recorded its observations on the thesis, which were divided between explanation and correction and the student’s defense of her message and the discussion ended, the committee decided to evaluate the thesis, and decided to grant the student a master’s degree with a Pass grade.
Abstract
The MXene was employed to enhance the ZnO nanoparticles and for the synthesized heterostructured photocatalyst to photodegrade harmful pharmaceuticals under simulated sunlight. The MXene was hydrothermally prepared from a MAX phase (Ti3AlC2) by utilizing NH4HF2 as an etchant, followed by chemical synthesis of a ZnO/TiO2 MXene photocatalyst. XRD, FTIR, FESEM, UV-vis DRS, TEM, and BET analysis were used to analyze the prepared photocatalysts. The results showed that ZnO-TiO2 MXene had excellent performance in the elimination of the ceftriaxone sodium and carbamazepine compounds, with an evaluated efficiency of 99.4% and 99.6%.
